GLP-1 drug costs represented an average of 10.5% of total annual insurance claims in 2024, up from 8.9% in 2023 and 6.9% in 2022, IFEBP found
It means retatrutide, like all GLP-1 class medications, works best as a sustained treatment rather than a temporary intervention
E-values were calculated for pre-specified outcomes to assess the potential influence of unmeasured confounders 52
However, it is invasive, expensive, and requires visits to a clinic
By activating these two critical pathways, tirzepatide can help regulate blood sugar and reduce appetite, creating an environment in which your body is more responsive to weight-loss efforts
They offer continuous support throughout your weight loss journey to ensure long-term success